127 related articles for article (PubMed ID: 16978222)
1. Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS.
Czibere A; Prall WC; Zerbini LF; Jäger M; Kobbe G; Knipp S; Libermann TA; Haas R; Aivado M
Br J Haematol; 2006 Nov; 135(3):355-7. PubMed ID: 16978222
[TBL] [Abstract][Full Text] [Related]
2. The nonsteroidal anti-inflammatory drug Exisulind selectively induces apoptosis via JNK in secondary acute myeloid leukemia after myelodysplastic syndrome.
Czibere A; Prall WC; Zerbini LF; Grall F; Craigie EC; Ulrich SD; Giagounidis AA; Haas R; Libermann TA; Aivado M
Cell Cycle; 2005 Jun; 4(6):812-7. PubMed ID: 15970671
[TBL] [Abstract][Full Text] [Related]
3. Alpha-tocopheryl succinate sensitizes human colon cancer cells to exisulind-induced apoptosis.
Lim SJ; Lee YJ; Park DH; Lee E; Choi MK; Park W; Chun KH; Choi HG; Cho JS
Apoptosis; 2007 Feb; 12(2):423-31. PubMed ID: 17191116
[TBL] [Abstract][Full Text] [Related]
4. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes: the complexity of stem-cell diseases.
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD
Nat Rev Cancer; 2007 Feb; 7(2):118-29. PubMed ID: 17251918
[TBL] [Abstract][Full Text] [Related]
7. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
10. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
Singh R; Cadeddu RP; Fröbel J; Wilk CM; Bruns I; Zerbini LF; Prenzel T; Hartwig S; Brünnert D; Schroeder T; Lehr S; Haas R; Czibere A
Apoptosis; 2011 Sep; 16(9):889-901. PubMed ID: 21739277
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells.
Tong FK; Chow S; Hedley D
Cytometry B Clin Cytom; 2006 May; 70(3):107-14. PubMed ID: 16498671
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Doppel protein in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Comincini S; Benatti C; Azzalin A; Nano R; Rosti V; Ferretti L; Invernizzi R
Br J Haematol; 2005 Mar; 128(6):877-84. PubMed ID: 15755294
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
14. Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib.
Heidel F; Cortes J; Rücker FG; Aulitzky W; Letvak L; Kindler T; Huber C; Döhner H; Kantarjian H; Fischer T
Cancer; 2007 Mar; 109(5):907-14. PubMed ID: 17285599
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis as a cell biological abnormality in myelodysplasia.
Yoshida Y; Kawabata H; Anzai N; Tohyama K
Pathol Biol (Paris); 1997 Sep; 45(7):573-8. PubMed ID: 9404482
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
19. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
[TBL] [Abstract][Full Text] [Related]
20. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
